Key result
Yoga improves cardiac autonomic function in type 2 diabetes, yielding ~60% higher SDNN vs control.
Why the study?
Diabetes mellitus is often accompanied by autonomic neuropathy and reduced heart rate variability, which increases cardiovascular risk, and yoga has shown promise as a non-pharmacological intervention to improve autonomic function.
Does a 12-week yoga intervention improve cardiac autonomic function in adults with type 2 diabetes?
RCT (n=90)
Single-blind (outcome assessors and data analysts blinded)
Computer-generated randomization process (1:1 ratio)
No
Does a 12-week yoga intervention improve cardiac autonomic function in adults with type 2 diabetes?
Standardized Mean Difference: 0.88
Absolute Event Rate: 70.48% vs 44.1%
p-value: p=0.01
A 12-week yoga program significantly improves cardiac autonomic function, as measured by heart rate variability, in patients with type 2 diabetes.
Supports yoga as adjunctive therapy for autonomic function in type 2 diabetes; extends randomized evidence for nonpharmacologic interventions.
Background. Diabetes mellitus is a chronic condition often accompanied by autonomic neuropathy and reduced heart rate variability (HRV), which is associated with increased cardiovascular risk. Yoga has shown promise as a non-pharmacological intervention to improve autonomic function in various populations. Objectives. The primary objective of this randomized controlled trial was to evaluate the effects of a 12-week yoga intervention on cardiac autonomic function, as measured by HRV parameters, in patients with type 2 diabetes. Methods. Ninety adults with type 2 diabetes were randomly assigned to either a yoga intervention group (n = 45) or a control group (n = 45). The yoga group participated in a 60-minute yoga session three times per week for 12 weeks, while the control group maintained their usual care. Short-term HRV was assessed at baseline and post-intervention using time-domain (SDNN, RMSSD, pNN50) and frequency-domain (LF, HF, LF/HF ratio) parameters. Additional cardiometabolic risk factors were also evaluated. Results. The yoga group demonstrated significant improvements in time-domain HRV parameters, including mean RR, mean HR, SDNN, RMSSD, and pNN50 (p < 0.05). In the frequency domain, the yoga group showed a significant increase in HF power (p = 0.03) and reductions in LF power (p = 0.02) and LF/HF ratio (p = 0.04), suggesting enhanced parasympathetic activity and better autonomic balance. The control group showed a decline in SDNN and pNN50 over the study period. Conclusions. A 12-week yoga program significantly improved cardiac autonomic function in individuals with type 2 diabetes, as demonstrated by positive shifts in both time-domain and frequency-domain HRV measures. These results indicate that yoga could serve as a helpful complementary approach to standard diabetes treatment, potentially lowering the risk of cardiovascular issues by enhancing autonomic regulation.
No takes yet. Share an insight, caveat, or question.
Mahalingam et al. (2025) conducted an RCT in Type 2 diabetes (n=90). Yoga vs. Standard care (wait-list control) was evaluated on Cardiac autonomic function measured by SDNN (Standard deviation of all normal RR intervals) (SMD 0.88, p=0.01). A 12-week yoga intervention significantly improved cardiac autonomic function in patients with type 2 diabetes, increasing SDNN to 70.48 ms compared to a decline to 44.10 ms in the control group.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: